Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InMed Pharmaceuticals (INM) Inventory (2021 - 2025)

Historic Inventory for InMed Pharmaceuticals (INM) over the last 5 years, with Q3 2025 value amounting to $890807.0.

  • InMed Pharmaceuticals' Inventory fell 2698.74% to $890807.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $890807.0, marking a year-over-year decrease of 2698.74%. This contributed to the annual value of $961173.0 for FY2025, which is 2275.54% down from last year.
  • InMed Pharmaceuticals' Inventory amounted to $890807.0 in Q3 2025, which was down 2698.74% from $961173.0 recorded in Q2 2025.
  • In the past 5 years, InMed Pharmaceuticals' Inventory registered a high of $2.5 million during Q2 2022, and its lowest value of $744839.0 during Q4 2023.
  • Over the past 5 years, InMed Pharmaceuticals' median Inventory value was $1.2 million (recorded in 2024), while the average stood at $1.3 million.
  • Per our database at Business Quant, InMed Pharmaceuticals' Inventory skyrocketed by 6317.46% in 2022 and then crashed by 5383.72% in 2023.
  • Over the past 5 years, InMed Pharmaceuticals' Inventory (Quarter) stood at $988822.0 in 2021, then soared by 63.17% to $1.6 million in 2022, then tumbled by 53.84% to $744839.0 in 2023, then soared by 48.13% to $1.1 million in 2024, then dropped by 19.26% to $890807.0 in 2025.
  • Its last three reported values are $890807.0 in Q3 2025, $961173.0 for Q2 2025, and $813970.0 during Q1 2025.